Discontinued — last reported Q3 '25

Other

Redeemable noncontrolling interests in subsidiaries

GE HealthCare Technologies Redeemable noncontrolling interests in subsidiaries increased by 4.3% to $218.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.3%, from $211.00M to $218.00M. Over 5 years (FY 2020 to FY 2025), Redeemable noncontrolling interests in subsidiaries shows relatively stable performance with a -1.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryLiquidity
SignalLower is better
VolatilityStable
First reportedQ3 2021
Last reportedQ3 2025

How to read this metric

An increase indicates a higher potential future cash outflow obligation to minority shareholders, which may impact liquidity.

Detailed definition

This represents the portion of equity in a subsidiary that is attributable to noncontrolling interests, which is subject...

Peer comparison

Found in companies with complex organizational structures or joint venture arrangements; peers with significant M&A activity often carry these balances.

Metric ID: other_redeemable_noncontrolling_interest_equity_carrying_amount

Historical Data

18 periods
 Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$220.00M$229.00M$220.00M$198.00M$230.00M$201.00M$209.00M$161.00M$165.00M$177.00M$177.00M$177.00M$188.00M$211.00M$220.00M$204.00M$209.00M$218.00M
QoQ Change+4.1%-3.9%-10.0%+16.2%-12.6%+4.0%-23.0%+2.5%+7.3%+0.0%+0.0%+6.2%+12.2%+4.3%-7.3%+2.5%+4.3%
YoY Change+4.5%-12.2%-5.0%-18.7%-28.3%-11.9%-15.3%+9.9%+13.9%+19.2%+24.3%+15.3%+11.2%+3.3%
Range$161.00M$230.00M
CAGR-0.2%
Avg YoY Growth+0.7%
Median YoY Growth+3.9%
Current Streak2 quarters growth

Redeemable noncontrolling interests in subsidiaries at Other Companies

Frequently Asked Questions

What is GE HealthCare Technologies's redeemable noncontrolling interests in subsidiaries?
GE HealthCare Technologies (GEHC) reported redeemable noncontrolling interests in subsidiaries of $218.00M in Q1 2026.
How has GE HealthCare Technologies's redeemable noncontrolling interests in subsidiaries changed year-over-year?
GE HealthCare Technologies's redeemable noncontrolling interests in subsidiaries increased by 3.3% year-over-year, from $211.00M to $218.00M.
What is the long-term trend for GE HealthCare Technologies's redeemable noncontrolling interests in subsidiaries?
Over 5 years (2020 to 2025), GE HealthCare Technologies's redeemable noncontrolling interests in subsidiaries has grown at a -1.3% compound annual growth rate (CAGR), from $223.00M to $209.00M.
What does redeemable noncontrolling interests in subsidiaries mean?
The value of minority-owned stakes in subsidiaries that the company may be required to buy back under certain conditions.